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made using an existing code of practice for non-FFF beams, 
NCS-18 [1]. Therefore kQ values were obtained provided by 
the code of practice. The differences of the NCS-18 kQ values 
between FFF and FF beams were compared with the 
measured differences. 
 
 
 
Results: The average kQ of the six NCS-18 recommended 
chambers (i.e. the not waterproof types) are presented in 
the Table. Comparison between FFF and FF beams of the 
same nominal energy and pdd(10) show negligible differences 
of -0.001 (8) and 0.000 (9) for 6 and 10 MV respectively. 
Based on NCS-18, using quality index TPR20,10 the differences 
in kQ also show negligible deviations of respectively -0.002 (8) 
and -0.003 (9). The uncertainties, represented as the last 
significant digit between brackets, are reported with a 
coverage factor, k = 2. 
 
 
Conclusions: The differences between FFF and FF clinical 
photon beams of 6 and 10 MV for measured kQ values of six 
reference type ionization chambers with the same value for 
the beam quality index pdd(10) are negligible (< 0.001). 
Application of a TPR20,10 based protocol results in slightly 
higher differences (< 0.003). All differences are within the 
reported uncertainties. 
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Purpose/Objective: The combined simultaneous use of MRI 
and MV photon irradiations is one of the most promising 
innovations of cancer radiotherapy as it offers the capability 
of using non-ionizing radiation for high quality imaging with 
tissue selectivity to drive the delivery of therapeutic doses of 
ionizing radiation to tumour volumes. Clinical application of 
such facilities presents new dosimetric and radiobiological 
challenges. 
The aim of this work was to use 4 different chamber types 
and alanine dosimeters to determine correction factors and 
optimum set up for ionization chamber based dosimetry in an 
MR-linac. 
Materials and Methods: Measurements were made in the 
UMC Utrecht MR-linac facility (Elekta). Absorbed dose was 
measured at the isocentre in a static vertical beam, with the 
detector axis perpendicular to both the beam and magnetic 
field. A 10 cm x 10 cm field was set at the isocentre and 
measurements were made at 5cm depth in a water-
equivalent full scatter phantom. The chambers used were a 
PTW Farmer-type chamber (TW30012-1), a PTW waterproof 
Farmer-type chamber (TW30013), a 2611-type chamber and 
an Exradin A1SL chamber. Alanine pellets were used in a 
Farmer-shaped PEEK holder. 
Measurements were made in the conventional way to 
determine the corrections required for the effects due to 
both polarity and ion recombination. To investigate machine 
linearity, 500 – 5000MU were delivered to alanine pellets. 
Results: The alanine dosimeters used in the UMC-Utrecht MR-
linac were used to calibrate the MR-linac output. This was 
determined in terms of cGy / MU, using machine monitor 
units as the reference, as well as in terms of cGy / monitor 
chamber nC. The machine calibration was used to determine 
the dose delivered to each ionization chamber. For the same 
beams, each chamber also measured the total dose 
delivered. These results are shown in table 1. 
 
Table 1. The dose as measured by each of four ionisation 
chambers compared to the dose determined via calibration of 
the MR-linac output using alanine. 
Conclusions: The two Farmer chamber calibrations deviate 
from the alanine based calibration by 1.9% and measure a 
greater dose than the alanine. The 2611 chamber differs from 
the alanine measurement by 0.3% and measures a smaller 
dose than the alanine. The A1SL chamber differs by 2% from 
the alanine, measuring a smaller dose for the same 
conditions. 
The effect of a 1.5 T field on the polarity and ion 
recombination corrections was expected to be small (Smit et 
al. 2013) and the results of this work agree with this for all 
chamber types. Within uncertainty, the dose response of 
alanine and the 2611 monitor ionization chamber was linear 
with delivered monitor units. 
The correction for the effect of the magnetic field will be 
determined by measurements on a theratron cobalt-60 
facility which has just had a 1.5T magnet installed. 
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